Even though post-translational modifications of the SRC protein have been widely studied as the underlying cause of high SRC activity in cancer, less is known about activating variation of the SRC gene in human CRC besides the somatic truncating mutation SRC531 [57,58]. This evidence concerns the gene SRC and cancer.